232 related articles for article (PubMed ID: 22532252)
1. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in the management of nasopharyngeal carcinoma.
Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
[TBL] [Abstract][Full Text] [Related]
3. Head and neck MRI-based T stage and [
Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of simultaneous whole-body
Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
6. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
7. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
[TBL] [Abstract][Full Text] [Related]
8. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M
Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963
[TBL] [Abstract][Full Text] [Related]
9. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients.
Chen YK; Su CT; Ding HJ; Chi KH; Liang JA; Shen YY; Chen LK; Yeh CL; Liao AC; Kao CH
Anticancer Res; 2006; 26(2B):1471-7. PubMed ID: 16619560
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
Huang B; Chan T; Kwong DL; Chan WK; Khong PL
AJR Am J Roentgenol; 2012 Jul; 199(1):169-74. PubMed ID: 22733909
[TBL] [Abstract][Full Text] [Related]
12. Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
Piao Y; Cao C; Xu Y; Huang S; Jiang F; Jin T; Jin Q; Hua Y; Hu Q; Chen X
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):353-359. PubMed ID: 33782748
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
[TBL] [Abstract][Full Text] [Related]
17. Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma?
Wu IS; Hung GU; Chang BL; Liu CK; Chang TH; Lee HS; Chen MK
Ear Nose Throat J; 2016; 95(4-5):178-84. PubMed ID: 27140019
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
Dong Y; Zhang X; Wang S; Chen S; Ma C
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma].
Su Y; Zhao C; Xie CM; Lu LX; Sun Y; Han F; Wu HB; Cui NJ; Zeng ZY; Lu TX
Ai Zheng; 2006 May; 25(5):521-5. PubMed ID: 16687067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
